It’s been kind of a wild week, and you’re all probably due for a slightly less verbose Curve today. (It’s not a shorter newsletter, though … but that’s a problem
Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv
There are two ways of looking at the ruling against AstraZeneca in its IRA lawsuit. (If you want to catch up quick on the basics, Bloomberg Law has you covered.)